A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Encephalitis
Interventions
BIOLOGICAL

0.5ml experimental vaccine on day 0,7 Vero cell-derived inactivated Japanese Encephalitis vaccine

Vero cell-derived inactivated Japanese Encephalitis vaccine produced by Shandong Hengye Biotech Co., Ltd./0.5ml, two doses with 7 days interval, a booster dose 12 months after the first dose

BIOLOGICAL

0.5ml experimental vaccine on day 0,28 Vero cell-derived inactivated Japanese Encephalitis vaccine

Vero cell-derived inactivated Japanese Encephalitis vaccine produced by Shandong Hengye Biotech Co., Ltd./0.5ml, two doses with 28 days interval, a booster dose 12 months after the first dose

BIOLOGICAL

0.5ml active comparator vaccine on day 0,7 inactivated freeze-dried Japanese Encephalitis vaccine(Vero cell)

inactivated freeze-dried Japanese Encephalitis vaccine(Vero cell) produced by Beijing Tiantan Biological Products Co., Ltd. /0.5ml, two doses with 7 days interval, a booster dose 12 months after the first dose

Trial Locations (1)

221300

Pizhou Center for Disease Control and Prevention, Xuzhou

All Listed Sponsors
collaborator

Shandong Hengye Biotech Co., Ltd.

UNKNOWN

lead

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

NCT02367664 - A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants | Biotech Hunter | Biotech Hunter